Literature DB >> 19052281

Medication administration through enteral feeding tubes.

Nancy Toedter Williams1.   

Abstract

PURPOSE: An overview of enteral feeding tubes, drug administration techniques, considerations for dosage form selection, common drug interactions with enteral formulas, and methods to minimize tube occlusion is given.
SUMMARY: Enteral nutrition through a feeding tube is the preferred method of nutrition support in patients who have a functioning gastrointestinal tract but who are unable to be fed orally. This method of delivering nutrition is also commonly used for administering medications when patients cannot swallow safely. However, several issues must be considered with concurrent administration of oral medications and enteral formulas. Incorrect administration methods may result in clogged feeding tubes, decreased drug efficacy, increased adverse effects, or drug-formula incompatibilities. Various enteral feeding tubes are available and are typically classified by site of insertion and location of the distal tip of the feeding tube. Liquid medications, particularly elixirs and suspensions, are preferred for enteral administration; however, these formulations may be hypertonic or contain large amounts of sorbitol, and these properties increase the potential for adverse effects. Before solid dosage forms are administered through the feeding tube, it should be determined if the medications are suitable for manipulation, such as crushing a tablet or opening a capsule. Medications should not be added directly to the enteral formula, and feeding tubes should be properly flushed with water before and after each medication is administered. To minimize drug-nutrient interactions, special considerations should be taken when administering phenytoin, carbamazepine, warfarin, fluoroquinolones, and proton pump inhibitors via feeding tubes. Precautions should be implemented to prevent tube occlusions, and immediate intervention is required when blockages occur.
CONCLUSION: Successful drug delivery through enteral feeding tubes requires consideration of the tube size and placement as well as careful selection and appropriate administration of drug dosage forms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052281     DOI: 10.2146/ajhp080155

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  32 in total

1.  Evaluation of three brands of drug interaction software for use in intensive care units.

Authors:  Adriano Max Moreira Reis; Silvia Helena De Bortoli Cassiani
Journal:  Pharm World Sci       Date:  2010-10-21

Review 2.  [Enteral feeding tubes for critically ill patients].

Authors:  J Braun; T Bein; C H R Wiese; B M Graf; Y A Zausig
Journal:  Anaesthesist       Date:  2011-04       Impact factor: 1.041

Review 3.  Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients.

Authors:  Lizanne Béïque; Rosemary Zvonar
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

Review 4.  Clinical nutrition and drug interactions.

Authors:  Aygin Bayraktar Ekincioğlu; Kutay Demirkan
Journal:  Ulus Cerrahi Derg       Date:  2013-11-14

5.  Development and evaluation of an algorithm to facilitate drug prescription for inpatients with feeding tubes.

Authors:  Kristina Lohmann; Julia Freigofas; Julian Leichsenring; Chantal Marie Wallenwein; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Eur J Clin Pharmacol       Date:  2015-02-19       Impact factor: 2.953

6.  Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected.

Authors:  Kristina Lohmann; Julia Ferber; Alexander Francesco Josef Send; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Eur J Clin Pharmacol       Date:  2014-01-28       Impact factor: 2.953

7.  Orogastric administration of crushed darunavir tablets for a critically ill patient.

Authors:  Catherine H Kim; Katie M Muzevich; Patricia P Fulco
Journal:  Can J Hosp Pharm       Date:  2014-01

8.  In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes.

Authors:  Kristin Reindel; Fang Zhao; Susan Hughes; Vivek S Dave
Journal:  Hosp Pharm       Date:  2017-09-25

9.  In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube Administration.

Authors:  Ping Ren; Minglei Cui; Om Anand; Li Xia; Zhuojun J Zhao; Dajun Sun; Trueman Sharp; Dale P Conner; John Peters; Wenlei Jiang; Ethan Stier; Xiaojian Jiang
Journal:  AAPS J       Date:  2017-09-06       Impact factor: 4.009

Review 10.  Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis.

Authors:  Irakoze Laurent; Siying Tang; Manirakiza Astère; Kan Ran Wang; Shuhua Deng; Ling Xiao; Qi Fu Li
Journal:  Endocrine       Date:  2018-03-23       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.